SCHEMBL5041250

SCHEMBL5041250

COC(C(=O)O)c1ccc(Br)cc1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
APLNR P35414 4/20 0.50
DGAT1 O75907 1/20 0.41
BMP1 P13497 1/20 0.39
FPR2 P25090 1/20 0.39
NPC1 O15118 2/20 0.37
LMNA P02545 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP3 P08254 1/20 0.37
MMP7 P09237 1/20 0.37
MMP9 P14780 1/20 0.37
MMP13 P45452 1/20 0.37
GAA P10253 1/20 0.37
PPARG P37231 2/20 0.36
PPARA Q07869 2/20 0.36
PTGS1 P23219 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5041566 0.87 ALDH1A1 (0.50) ALDH1A1L3MBTL1APLNRDGAT1BMP1
SCHEMBL5040984 0.82 MIF (0.39) ALDH1A1L3MBTL1GAAPPARGPPARA
SCHEMBL5037321 0.81 NPC1 (0.40) ALDH1A1L3MBTL1APLNRDGAT1BMP1
SCHEMBL3172075 0.81 KDM4E (0.50) ALDH1A1L3MBTL1KDM4EGLA
SCHEMBL2347876 0.81 PTGS2 (0.45) PTGS1PTGS2KDM4E
SCHEMBL31147960 0.79 AKR1C3 (0.43) ALDH1A1L3MBTL1LMNAGAAPPARG
SCHEMBL31147959 0.79 AKR1C3 (0.43) ALDH1A1L3MBTL1LMNAGAAPPARG
SCHEMBL5042110 0.78 PDE2A (0.54) ALDH1A1GAAPPARGKDM4E
SCHEMBL1679175 0.78 PTGS1 (0.51) APLNRDGAT1FPR2MMP1MMP2
SCHEMBL5037418 0.76 ALDH1A1 (0.51) ALDH1A1L3MBTL1LMNAGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 ALDH1A1 519/4885L3MBTL1 1475/4885APLNR 736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.